Prenatal exposure to the environmental obesogen tributyltin predisposes multipotent stem cells to become adipocytes

Molecular Endocrinology

Volumn 24, Issue 3, 2010, Pages 526-539

  Kirchner, Séverine ^a   Kieu, Tiffany ^a   Chow, Connie ^a   Casey, Stephanie ^a   Blumberg, Bruce ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMICAL COMPOUND; FATTY ACID BINDING PROTEIN 4; OBESOGEN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA ANTAGONIST; ROSIGLITAZONE; TRIBUTYLTIN; UNCLASSIFIED DRUG;

ADIPOCYTE; ADIPOGENESIS; ADIPOSE TISSUE; ANIMAL CELL; ARTICLE; BONE DEVELOPMENT; CELL DIFFERENTIATION; CELL LEVEL; CONTROLLED STUDY; DRUG EXPOSURE; GENE EXPRESSION; GENE INDUCTION; GENE LOCUS; HUMAN; HUMAN CELL; IN VITRO STUDY; LIPID STORAGE; MARKER GENE; MULTIPOTENT STEM CELL; NONHUMAN; PRENATAL EXPOSURE; PRIORITY JOURNAL; SENSITIZATION;

ADIPOCYTES; ANIMALS; CELL DIFFERENTIATION; CELL PROLIFERATION; CELLS, CULTURED; FEMALE; FLOW CYTOMETRY; HUMANS; MALE; MICE; MICE, INBRED C57BL; MULTIPOTENT STEM CELLS; POLYMERASE CHAIN REACTION; PREGNANCY; TRIALKYLTIN COMPOUNDS;

ANIMALIA; MUS;

EID: 77249160182     PISSN: 08888809     EISSN: None     Source Type: Journal    
DOI: 10.1210/me.2009-0261     Document Type: Article

References (64)

1. Herbert A 2008 The fat tail of obesity as told by the genome. Curr Opin Clin Nutr Metab Care 11:366-370
2. Power C, Jefferis BJ 2002 Fetal environment and subsequent obesity: a study of maternal smoking. Int J Epidemiol 31:413-419
3. Mantena SK, King AL, Andringa KK, Eccleston HB, Bailey SM 2008 Mitochondrial dysfunction and oxidative stress in the pathogenesis of alcohol- and obesity-induced fatty liver diseases. Free Radic Biol Med 44:1259-1272
4. Hill JO, Peters JC 1998 Environmental contributions to the obesity epidemic. Science 280:1371-1374
5. Garruti G, Cotecchia S, Giampetruzzi F, Giorgino F, Giorgino R 2008 Neuroendocrine deregulation of food intake, adipose tissue and the gastrointestinal system in obesity and metabolic syndrome. J Gastrointestin Liver Dis 17:193-198
6. Rippe JM, Hess S 1998 The role of physical activity in the prevention and management of obesity. J Am Diet Assoc 98:S31-S38
7. Baillie-Hamilton PF 2002 Chemical toxins: a hypothesis to explain the global obesity epidemic. J Altern Complement Med 8:185-192
8. Heindel JJ 2003 Endocrine disruptors and the obesity epidemic. Toxicol Sci 76:247-249
9. Curhan GC, Willett WC, Rimm EB, Spiegelman D, Ascherio AL, Stampfer MJ 1996 Birth weight and adult hypertension, diabetes mellitus, and obesity in US men. Circulation 94:3246-3250
10. Barker DJ, Fall CH 1993 Fetal and infant origins of cardiovascular disease. Arch Dis Child 68:797-799
11. Bertram CE, Hanson MA 2001 Animal models and programming of the metabolic syndrome. Br Med Bull 60:103-121
12. Budge H, Gnanalingham MG, Gardner DS, Mostyn A, Stephenson T, Symonds ME 2005 Maternal nutritional programming of fetal adipose tissue development: long-term consequences for later obesity. Birth Defects Res C Embryo Today 75:193-199
13. Taylor PD, Poston L 2007 Developmental programming of obesity in mammals. Exp Physiol 92:287-298
14. Gluckman PD, Hanson MA, Beedle AS, Raubenheimer D 2008 Fetal and neonatal pathways to obesity. Front Horm Res 36:61-72
15. Mathers JC 2007 Early nutrition: impact on epigenetics. Forum Nutr 60:42-48
16. Mikkelsen TS, Hanna J, Zhang X, Ku M, Wernig M, Schorderet P, Bernstein BE, Jaenisch R, Lander ES, Meissner A 2008 Dissecting direct reprogramming through integrative genomic analysis. Nature 454:49-55
17. Rees WD, McNeil CJ, Maloney CA 2008 The roles of PPARs in the fetal origins of metabolic health and disease. PPAR Res 2008: 459030
18. Grün F, Blumberg B 2007 Perturbed nuclear receptor signaling by environmental obesogens as emerging factors in the obesity crisis. Rev Endocr Metab Disord 8:161-171
19. Grün F, Watanabe H, Zamanian Z, Maeda L, Arima K, Cubacha R, Gardiner DM, Kanno J, Iguchi T, Blumberg B 2006 Endocrinedisrupting organotin compounds are potent inducers of adipogenesis in vertebrates. Mol Endocrinol 20:2141-2155
20. Casals-Casas C, Feige JN, Desvergne B 2008 Interference of pollutants with PPARs: endocrine disruption meets metabolism. Int J Obes (Lond) Suppl 6: S53-S61
21. Grün F, Blumberg B 2006 Environmental obesogens: organotins and endocrine disruption via nuclear receptor signaling. Endocrinology 147(Suppl 6):S50-S55
22. Golub M, Doherty J 2004 Triphenyltin as a potential human endocrine disruptor. J Toxicol Environ Health B Crit Rev 7:281-295
23. Oberdörster E, McClellan-Green P 2002 Mechanisms of imposex induction in the mud snail, Ilyanassa obsoleta: TBT as a neurotoxin and aromatase inhibitor. Mar Environ Res 54:715-718
24. McAllister BG, Kime DE 2003 Early life exposure to environmental levels of the aromatase inhibitor tributyltin causes masculinisation and irreversible sperm damage in zebrafish (Danio rerio). Aquat Toxicol 65:309-316
25. Shimasaki Y, Kitano T, Oshima Y, Inoue S, Imada N, Honjo T 2003 Tributyltin causes masculinization in fish. Environ Toxicol Chem 22:141-144
26. Ogata R, Omura M, Shimasaki Y, Kubo K, Oshima Y, Aou S, Inoue N 2001 Two-generation reproductive toxicity study of tributyltin chloride in female rats. J Toxicol Environ Health A 63:127-144
27. Avram MM, Avram AS, James WD 2007 Subcutaneous fat in normal and diseased states 3. Adipogenesis: from stem cell to fat cell. J Am Acad Dermatol 56:472-492
28. Rosen ED, MacDougald OA 2006 Adipocyte differentiation from the inside out. Nat Rev Mol Cell Biol 7:885-896
29. Schäffler A, Büchler C 2007 Concise review: adipose tissue-derived stromal cells - basic and clinical implications for novel cell-based therapies. Stem Cells 25:818-827
30. Janderová L, McNeil M, Murrell AN, Mynatt RL, Smith SR 2003 Human mesenchymal stem cells as an in vitro model for human adipogenesis. Obes Res 11:65-74
31. Gimble JM, Robinson CE,WuX, Kelly KA, Rodriguez BR, Kliewer SA, Lehmann JM, Morris DC 1996 Peroxisome proliferator-activated receptor-γ activation by thiazolidinediones induces adipogenesis in bone marrow stromal cells. Mol Pharmacol 50:1087-1094
32. Muruganandan S, Roman AA, Sinal CJ 2009 Adipocyte differentiation of bone marrow-derived mesenchymal stem cells: cross talk with the osteoblastogenic program. Cell Mol Life Sci 66:236-253
33. Peister A, Mellad JA, Larson BL, Hall BM, Gibson LF, Prockop DJ 2004 Adult stem cells from bone marrow (MSCs) isolated from different strains of inbred mice vary in surface epitopes, rates of proliferation, and differentiation potential. Blood 103:1662-1668
34. Burris TP, Pelton PD, Zhou L, Osborne MC, Cryan E, Demarest KT 1999 A novel method for analysis of nuclear receptor function at natural promoters: peroxisome proliferator-activated receptor γ agonist actions on aP2 gene expression detected using branched DNA messenger RNA quantitation. Mol Endocrinol 13:410-417
35. Ibrahimi A, Teboul L, Gaillard D, Amri EZ, Ailhaud G, Young P, Cawthorne MA, Grimaldi PA 1994 Evidence for a common mechanism of action for fatty acids and thiazolidinedione antidiabetic agents on gene expression in preadipose cells. Mol Pharmacol 46: 1070-1076
36. Sul HS, Smas C, Mei B, Zhou L 2000 Function of pref-1 as an inhibitor of adipocyte differentiation. Int J Obes Relat Metab Disord 24(Suppl 4):S15-S19
37. Gregoire FM 2001 Adipocyte differentiation: from fibroblast to endocrine cell. Exp Biol Med (Maywood) 226:997-1002
38. Quarto N, Longaker MT 2006 FGF-2 inhibits osteogenesis in mouse adipose tissue-derived stromal cells and sustains their proliferative and osteogenic potential state. Tissue Eng 12:1405-1418
39. Hasegawa T, Oizumi K, Yoshiko Y, Tanne K, Maeda N, Aubin JE 2008 The PPARγ-selective ligand BRL-49653 differentially regulates the fate choices of rat calvaria versus rat bone marrow stromal cell populations. BMC Dev Biol 8:71
40. Liu X, Zhou GD, Lü XJ, Liu TY, Zhang WJ, Liu W, Cao YL 2007 [Potential of chondrogenesis of bone marrow stromal cells co-cultured with chondrocytes on biodegradable scaffold: in vivo experiment with pigs and mice]. Zhonghua Yi Xue Za Zhi 87:1929-1933
41. Benvenuti S, Cellai I, Luciani P, Deledda C, Baglioni S, Giuliani C, Saccardi R, Mazzanti B, Dal Pozzo S, Mannucci E, Peri A, Serio M 2007 Rosiglitazone stimulates adipogenesis and decreases osteo-blastogenesis in human mesenchymal stem cells. J Endocrinol Invest 30:RC26-RC30
42. Tchoukalova YD, Sarr MG, Jensen MD 2004 Measuring committed preadipocytes in human adipose tissue from severely obese patients by using adipocyte fatty acid binding protein. Am J Physiol Regul Integr Comp Physiol 287:R1132-R1140
43. Kanayama T, Kobayashi N, Mamiya S, Nakanishi T, Nishikawa J 2005 Organotin compounds promote adipocyte differentiation as agonists of the peroxisome proliferator-activated receptor γ/retinoid X receptor pathway. Mol Pharmacol 67:766-774
44. Chamberlain G, Fox J, Ashton B, Middleton J 2007 Concise review: mesenchymal stem cells: their phenotype, differentiation capacity, immunological features, and potential for homing. Stem Cells 25: 2739-2749
45. Carfi' M, Croera C, Ferrario D, Campi V, Bowe G, Pieters R, Gribaldo L 2008 TBTC induces adipocyte differentiation in human bone marrow long term culture. Toxicology 249:11-18
46. Crossno Jr JT, Majka SM, Grazia T, Gill RG, Klemm DJ 2006 Rosiglitazone promotes development of a novel adipocyte population from bone marrow-derived circulating progenitor cells. J Clin Invest 116:3220-3228
47. Koh YJ, Kang S, Lee HJ, Choi TS, Lee HS, Cho CH, Koh GY 2007 Bone marrow-derived circulating progenitor cells fail to transdifferentiate into adipocytes in adult adipose tissues in mice. J Clin Invest 117:3684-3695
48. Takahashi S, Mukai H, Tanabe S, Sakayama K, Miyazaki T, Masuno H 1999 Butyltin residues in livers of humans and wild terrestrial mammals and in plastic products. Environ Pollut 106:213-218
49. Kannan K, Grove RA, Senthilkumar K, Henny CJ, Giesy JP 1999 Butyltin compounds in river otters (Lutra canadensis) from the northwestern United States. Arch Environ Contam Toxicol 36:462-468
50. Nielsen JB, Strand J 2002 Butyltin compounds in human liver. Environ Res 88:129-133
51. Tsuda T, Inoue T, Kojima M, Aoki S 1995 Daily intakes of tributyltin and triphenyltin compounds from meals. J AOAC Int 78: 941-943
52. Otto TC, Lane MD 2005 Adipose development: from stem cell to adipocyte. Crit Rev Biochem Mol Biol 40:229-242
53. Farmer SR 2005 Regulation of PPAR γ activity during adipogenesis. Int J Obes (Lond) 29(Suppl 1):S13-S16
54. Walkey CJ, Spiegelman BM 2008 A functional peroxisome proliferator-activated receptor-gamma ligand-binding domain is not required for adipogenesis. J Biol Chem 283:24290-24294
55. Yang W, Rachez C, Freedman LP 2000 Discrete roles for peroxisome proliferator-activated receptor γ and retinoid X receptor in recruiting nuclear receptor coactivators. Mol Cell Biol 20:8008-8017
56. Aubin JE 1998 Bone stem cells. J Cell Biochem (Suppl 30-31): 73-82
57. Song L, Tuan RS 2004 Transdifferentiation potential of human mesenchymal stem cells derived from bone marrow. FASEB J 18: 980-982
58. Akune T, Ohba S, Kamekura S, Yamaguchi M, Chung UI, Kubota N, Terauchi Y, Harada Y, Azuma Y, Nakamura K, Kadowaki T, Kawaguchi H 2004 PPAR γ insufficiency enhances osteogenesis through osteoblast formation from bone marrow progenitors. J Clin Invest 113:846-855
59. Post S, Abdallah BM, Bentzon JF, Kassem M 2008 Demonstration of the presence of independent pre-osteoblastic and pre-adipocytic cell populations in bone marrow-derived mesenchymal stem cells. Bone 43:32-39
60. Vickers MH 2007 Developmental programming and adult obesity: the role of leptin. Curr Opin Endocrinol Diabetes Obes 14:17-22
61. Prestwich TC, Macdougald OA 2007 Wnt/β-catenin signaling in adipogenesis and metabolism. Curr Opin Cell Biol 19:612-617
62. Takada I, Mihara M, Suzawa M, Ohtake F, Kobayashi S, Igarashi M, Youn MY, Takeyama K, Nakamura T, Mezaki Y, Takezawa S, Yogiashi Y, Kitagawa H, Yamada G, Takada S, Minami Y, Shibuya H, Matsumoto K, Kato S 2007 A histone lysine methyltransferase activated by non-canonical Wnt signalling suppresses PPAR-γ transactivation. Nat Cell Biol 9:1273-1285
63. Lillycrop KA, Phillips ES, Jackson AA, Hanson MA, Burdge GC 2005 Dietary protein restriction of pregnant rats induces and folic acid supplementation prevents epigenetic modification of hepatic gene expression in the offspring. J Nutr 135:1382-1386
64. Pfaffl MW 2001 A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 29:e45